Methodological considerations in cost of illness studies on Alzheimer disease
Authors:
- Nagede CostaNCNagede Costa
- Helene DerumeauxHDHelene Derumeaux
- Thomas RappTRThomas Rapp
- Valérie GarnaultVGValérie Garnault
- Laura FerlicoqLFLaura Ferlicoq
- Sophie GilletteSGSophie Gillette
- Sandrine AndrieuSASandrine Andrieu
- Bruno VellasBVBruno Vellas
- Michel LamureMLMichel Lamure
- Alain GrandAGAlain Grand
- Laurent MolinierLMLaurent Molinier
Open Access
- 11 September 2012
- journal article
- Published by Springer Nature in Health Economics Review
- Vol. 2 (1) , 18
Abstract
Cost-of-illness studies (COI) can identify and measure all the costs of a particular disease, including the direct, indirect and intangible dimensions. They are intended to provide estimates about the economic impact of costly disease. Alzheimer disease (AD) is a relevant example to review cost of illness studies because of its costliness.The aim of this study was to review relevant published cost studies of AD to analyze the method used and to identify which dimension had to be improved from a methodological perspective. First, we described the key points of cost study methodology. Secondly, cost studies relating to AD were systematically reviewed, focussing on an analysis of the different methods used. The methodological choices of the studies were analysed using an analytical grid which contains the main methodological items of COI studies. Seventeen articles were retained. Depending on the studies, annual total costs per patient vary from $2,935 to $52, 954. The methods, data sources, and estimated cost categories in each study varied widely. The review showed that cost studies adopted different approaches to estimate costs of AD, reflecting a lack of consensus on the methodology of cost studies. To increase its credibility, closer agreement among researchers on the methodological principles of cost studies would be desirable.Keywords
This publication has 50 references indexed in Scilit:
- Direct costs of Alzheimer’s disease in GermanyThe European Journal of Health Economics, 2010
- The Cost of Dementia in EuropePharmacoEconomics, 2009
- An Overview of Methods and Applications to Value Informal Care in Economic Evaluations of HealthcarePharmacoEconomics, 2008
- Economic impact of dementia in developing countries: an evaluation of costs of Alzheimer-type dementia in ArgentinaInternational Psychogeriatrics, 2006
- Cost-of-illness analysisHealth Policy, 2006
- SOUNDING BOARDHealth Policy, 1998
- Cost-of-Illness StudiesPharmacoEconomics, 1998
- Sensitivity Analysis in Health Economic and Pharmacoeconomic StudiesPharmacoEconomics, 1997
- Indirect Costs in Economic StudiesPharmacoEconomics, 1993
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984